Contract 75D30125D20478
Dynavax Technologies Corporation · Department Of Health And Human Services · January 21, 2026
Dynavax Technologies Corporation was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on January 21, 2026 for $2.60 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 11, 2026. If all options are exercised, the contract could reach $58.45 million.
Contract details
- PIID
- 75D30125D20478
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- January 21, 2026
- Latest action
- March 11, 2026
Description
ADULT VACCINES
Modification timeline
-
March 11, 2026Mod P00003 · Funding Only Action$2.63M
-
March 11, 2026Mod P00003$725.5K
-
March 5, 2026Mod P00002 · Funding Only Action$1.91M
-
January 21, 2026Mod P00001 · Funding Only Action$1.43M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125D20478?
Contract 75D30125D20478 is a federal contract awarded to Dynavax Technologies Corporation by Department Of Health And Human Services on January 21, 2026 for $2.60 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75D30125D20478?
Dynavax Technologies Corporation won contract 75D30125D20478 from Department Of Health And Human Services.
How much is contract 75D30125D20478 worth?
Contract 75D30125D20478 has obligated $2.60 million to date, with a total potential value of $58.45 million if all options are exercised.